ORI Updates

The Office of Research Integrity (ORI) is seeking a highly qualified candidate to manage activities related to assigned cases of alleged research misconduct in biomedical research studies. This position will be filled through an OASH Staff Fellow appointment (starting at a GS-11 level equivalent and up to a GS-13 level equivalent with a doctoral degree and relevant experience).

ORI’s FY2020 Annual Report has been updated and is now available for viewing and downloading.

ORI has released its FY 2020 Annual Report, which highlights activities over the past year regarding investigations of research misconduct, communications, ORI’s grant program, ORI research projects, and ORI’s compliance programs.

ORI’s Division of Investigative Oversight will be hiring a Health Scientist at the GS 13 level. A Bachelor's or graduate/higher level degree in an academic field related to the medical field, health sciences, or allied sciences is required

ORI found that Yibin Lin, Ph.D., former postdoctoral fellow, McGovern Medical School, UTHealth, engaged in research misconduct in research supported by U.S Public Health Service (PHS) funds, specifically National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).

ORI acknowledges that the COVID-19 pandemic is causing disruption to the businesses and research institutions that receive funding from the Public Health Service (PHS). During this period, ORI continues to perform mission critical functions and operations with ORI staff exercising maximum telework flexibilities. 

ORI is seeking a highly qualified researcher/analyst to join the project team studying outcomes associated with retractions and corrections requested in conjunction with ORI findings of research misconduct. This one-year appointment may be filled through an OASH Service Fellow appointment (requires a doctoral-level degree and post-doctoral experience), a funded detail of an existing federal employee, or an Intergovernmental Personnel Act appointment.

ORI found that Yihong Wan, Ph.D., Associate Professor, Department of Pharmacology, UTSMC, engaged in research misconduct in research supported by U.S Public Health Service (PHS) funds, specifically National Institute of Diabetes and Digestive and Kidney (NIDDK), National Institutes of Health (NIH).

ORI found that Charles A. Downs, former Adjunct Assistant Professor, Arizona Health Sciences Center, UA, engaged in research misconduct in research supported by U.S Public Health Service (PHS) funds, specifically National Center for Advancing Translation Sciences (NCATS), National Institutes of Health (NIH).

ORI found that Dr. David J. Panka, former HMS Instructor of Medicine, and former HMS Associate Professor of Medicine at BIDMC, engaged in research misconduct in research supported by U.S Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH).